HudaSalmanMD

Hematology • Stony Brook, NY

Hematologic Oncology

Associate Professor, Internal Medicine, Stony Brook University School of Medicine

Join to view full profile

Dr. Salman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Salman's full profile

Already have an account?

Office
Nicolls Rd
Stony Brook, NY 11794

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1999 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1996 - 1999
University of Jordan Faculty of MedicineClass of 1991

Certifications & Licensure

IN State Medical License 2021 - 2025
NY State Medical License 2015 - 2022
GA State Medical License 2013 - 2016
VA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012
TN State Medical License 2005 - 2007
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014, 2017-2018

Clinical Trials

CD4CAR for CD4+ Leukemia and Lymphoma Start of enrollment: 2020 Jul 09
Recruiting
Phase 1

Publications & Presentations

PubMed

59 citations
A compound chimeric antigen receptor strategy for targeting multiple myeloma.
Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, Xiao Shuai
Leukemia. 2018-02-01
57 citations
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML, or AML with ⩽ 30% blasts.
G. Garcia-Manero, Mikkael A. Sekeres, Miklos Egyed, Massimo Breccia, Carlos Graux
Leukemia. 2017-05-26
141 citations
Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
Kevin Chen, Masayuki Wada, Kevin G. Pinz, Hua Liu, K. W. Lin
Leukemia. 2017-01-12

Journal Articles

SALL1 expression in acute myeloid leukemia
iao Shuai,2,3,* Anh Thu Nguyen-Lefebvre,1,* Banabihari Giri,1 Mingqiang Ren,1 Michael Rauchman,4 Lynn Robbins,4 Wei Hou,2 Hasan Korkaya,1 and Yupo Ma2, Oncotarget, 1/26/2018

Press Mentions

Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New YorkJuly 13th, 2021
First in-Human Clinical Trial Targeting CD4 Protein for Aggressive T-cell Leukemia and Lymphoma to Be LaunchedAugust 7th, 2018